Search

Inefficient arsenic methylation capacity has been associated with developmental delay in children. The present study was designed to explore whether polymorphisms and haplotypes of arsenic methyltransferase ( AS3MT ), glutathione-S-transferase omegas ( GSTOs ), and purine nucleoside phosphorylase ( PNP ) affect arsenic methylation capacity and developmental delay. A case-control study was conducted from August 2010 to March 2014. All participants were recruited from the Shin Kong Wu Ho-Su Memorial Teaching Hospital. In total, 179 children with developmental delay and 88 children without delay were recruited. Urinary arsenic species, including arsenite (As III ), arsenate (As V ), monomethylarsonic acid (MMA V ), and dimethylarsinic acid (DMA V ) were measured using a high-performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. The polymorphisms of AS3MT , GSTO , and PNP were performed using the Sequenom MassARRAY platform with iPLEX Gold chemistry. Polymorphisms of AS3MT genes were found to affect susceptibility to developmental delay in children, but GSTO and PNP polymorphisms were not. Participants with AS3MT rs3740392 A/G + G/G genotype, compared with AS3MT rs3740392 A/A genotype, had a significantly lower secondary methylation index. This may result in an increased OR for developmental delay. Participants with the AS3MT high-risk haplotype had a significantly higher OR than those with AS3MT low-risk haplotypes [OR and 95% CI, 1.59 (1.08–2.34)]. This is the first study to show a joint dose-response effect of this AS3MT high-risk haplotype and inefficient arsenic methylation capacity on developmental delay. Our data provide evidence that AS3MT genes are related to developmental delay and may partially influence arsenic methylation capacity. [ABSTRACT FROM AUTHOR]

Objective: To examine the correlation of function, quality of life (QOL), and parental impact on developmental delayed children. Methods: Sixty parents of children with developmental delays ( M: F = 36:24, mean age 4 years and 2 months) and 56 parents of age-sex matched typical development children were included. Pediatric Outcomes Data Collection Instrument and Child Health Questionnaire for children, World Health Organization-QOL, Impact on Family Scale, and Hospital Anxiety and Depression Scale for parents were assessed. Results: Functional performance was correlated with physical component of QOL in children (correlation coefficients: 0.7-0.9; p < 0.01), age of children (0.3-0.4; p < 0.05) and parents (0.3; p < 0.05), maternal employment (0.3-0.4; p < 0.05), parental QOL (0.3-0.4; p < 0.01), family impact (−0.3 to −0.5; p < 0.01), and parental emotion (−0.3 to −0.4; p < 0.05). Conclusions: Children who exhibited higher levels of function had higher QOL, as did their parents, and less parental impact. [ABSTRACT FROM AUTHOR]